Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
April 2, 2016
Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases
William J Magnuson, Jacky T Yeung, Paul D Guillod, et al.
Clinical Lung Cancer
|
May 25, 2015
Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers
Matthew D Hellmann, Isrid Sturm, Zuzana Jirakova Trnkova, et al.
JAAD Case Reports
|
August 4, 2016
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy
Kathleen C Suozzi, Maximilian Stahl, Christine J Ko, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 1, 2022
Microwave Ablation versus Stereotactic Body Radiotherapy for Stage I Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis
Xiao Wu, Johannes Uhlig, Justin D Blasberg, et al.
Journal for Immunotherapy of Cancer
|
March 10, 2019
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
Daniel Carvajal-Hausdorf, Mehmet Altan, Vamsidhar Velcheti, et al.
JAMA Network Open
|
August 22, 2019
Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer
Johannes Uhlig, Meaghan Dendy Case, Justin D Blasberg, et al.
The Lancet. Oncology
|
September 20, 2020
Yale Cancer Center Precision Medicine Tumor Board: new technology, new drugs, and the value of repeat testing
Navid Hafez, Zenta Walther, Joseph P Eder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer
Gregory A Otterson, Miguel A Villalona-Calero, William Hicks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2019
Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy
Yuting Liu, Jon Zugazagoitia, Fahad Shabbir Ahmed, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 10, 2019
Immune Checkpoint Inhibitor-Associated Pericarditis
Mehmet Altan, Maria I Toki, Scott N Gettinger, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
International Journal of Radiation Oncology, Biology, Physics
|
April 2, 2016
Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases
William J Magnuson, Jacky T Yeung, Paul D Guillod, et al.
Clinical Lung Cancer
|
May 25, 2015
Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers
Matthew D Hellmann, Isrid Sturm, Zuzana Jirakova Trnkova, et al.
JAAD Case Reports
|
August 4, 2016
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy
Kathleen C Suozzi, Maximilian Stahl, Christine J Ko, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
May 1, 2022
Microwave Ablation versus Stereotactic Body Radiotherapy for Stage I Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis
Xiao Wu, Johannes Uhlig, Justin D Blasberg, et al.
Journal for Immunotherapy of Cancer
|
March 10, 2019
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
Daniel Carvajal-Hausdorf, Mehmet Altan, Vamsidhar Velcheti, et al.
JAMA Network Open
|
August 22, 2019
Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer
Johannes Uhlig, Meaghan Dendy Case, Justin D Blasberg, et al.
The Lancet. Oncology
|
September 20, 2020
Yale Cancer Center Precision Medicine Tumor Board: new technology, new drugs, and the value of repeat testing
Navid Hafez, Zenta Walther, Joseph P Eder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer
Gregory A Otterson, Miguel A Villalona-Calero, William Hicks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2019
Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy
Yuting Liu, Jon Zugazagoitia, Fahad Shabbir Ahmed, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 10, 2019
Immune Checkpoint Inhibitor-Associated Pericarditis
Mehmet Altan, Maria I Toki, Scott N Gettinger, et al.
Page
of 7